Ceribell, Inc. (CBLL) disclosed insider activity involving its Chief Technology Officer, Raymond Woo. On March 2, 2026, Woo sold 11,112 shares of the company's common stock for approximately $202,838. The shares were sold at a weighted average price between $18.25 and $18.26.
The company’s stock was trading at $17.77 at the time this report was compiled, which is modestly below the price realized by Woo in the transaction. Ceribell's market capitalization stood at $660.23 million.
On the same trading day, Woo acquired an identical number of shares - 11,112 - through the exercise of options. The exercise prices for those options ranged from $2.24 to $4.70, and the aggregate cost to Woo for the exercised options was $48,605.
Over the prior six months, CBLL shares had climbed roughly 42%. An analysis from InvestingPro cited in company commentary suggests the stock may be overvalued at current levels. The InvestingPro note referenced the availability of eight additional ProTips for subscribers, which reportedly include commentary on Ceribell's financial condition and profitability outlook.
Separately, Ceribell announced that it has secured FDA Breakthrough Device Designation for a Large Vessel Occlusion (LVO) stroke detection monitor. The device combines existing electroencephalography (EEG) hardware with an AI-based algorithm designed to identify LVO strokes early in hospital settings. If the device receives final regulatory clearance, it could become the first point-of-care technology for LVO detection.
In coverage developments, brokerage BTIG reaffirmed its Buy rating on Ceribell and maintained a $30 price target while highlighting an expected growth rate of nearly 30% for 2026.
Corporate governance activity included the resignation of director Lucian Iancovici from Ceribell’s board of directors, effective December 31, 2025. The company reported that the resignation occurred with no disagreements regarding the company’s operations or policies.
On the real estate and operations front, Ceribell extended its office leases in Sunnyvale, California. The extension runs through January 2028 and covers approximately 11,607 square feet, with a monthly rent of $34,821.
Taken together, the insider transactions, regulatory milestone, broker commentary, board change, and lease extension outline a series of operational and financial developments for Ceribell as the company advances its LVO detection technology and manages ongoing corporate requirements.